Algert Global’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Sell |
9,530
-240
| -2% | -$72.6K | 0.06% | 510 |
|
|
2025
Q1 | $3.24M | Hold |
9,770
| – | – | 0.08% | 430 |
|
|
2024
Q4 | $3.02M | Buy |
+9,770
| New | +$3.02M | 0.07% | 466 |
|
|
2024
Q3 | – | Sell |
-1,269
| Closed | -$356K | – | 1418 |
|
|
2024
Q2 | $356K | Buy |
+1,269
| New | +$356K | 0.01% | 1045 |
|
|
2023
Q3 | – | Sell |
-7,411
| Closed | -$1.71M | – | 1195 |
|
|
2023
Q2 | $1.71M | Sell |
7,411
-2,456
| -25% | -$567K | 0.07% | 446 |
|
|
2023
Q1 | $2.39M | Buy |
9,867
+1,217
| +14% | +$295K | 0.11% | 282 |
|
|
2022
Q4 | $2.51M | Sell |
8,650
-590
| -6% | -$171K | 0.14% | 222 |
|
|
2022
Q3 | $601K | Buy |
9,240
+4,417
| +92% | +$287K | 0.04% | 745 |
|
|
2022
Q2 | $345K | Hold |
4,823
| – | – | 0.03% | 880 |
|
|
2022
Q1 | $473K | Sell |
4,823
-586
| -11% | -$57.5K | 0.03% | 833 |
|
|
2021
Q4 | $458K | Buy |
+5,409
| New | +$458K | 0.06% | 569 |
|